Evolution of HIV treatment guidelines in high- and low-income countries: converging recommendations - Wikidata - wikimedia - TriplyDB

Evolution of HIV treatment guidelines in high- and low-income countries: converging recommendations

Evolution of HIV treatment guidelines in high- and low-income countries: converging recommendations

http://www.wikidata.org/entity/Q34321843

about

Autism screening and diagnosis in low resource settings: Challenges and opportunities to enhance research and services worldwide Contribution of human immunodeficiency virus type 1 minority variants to reduced drug susceptibility in patients on an integrase strand transfer inhibitor-based therapy Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.RNA Interference Therapies for an HIV-1 Functional Cure.Implementing parallel spreadsheet models for health policy decisions: The impact of unintentional errors on model projections.Simultaneous quantification of intracellular lamivudine and abacavir triphosphate metabolites by LC-MS/MS.

P2860

Q26781943-F9ADA50C-9AEF-46E0-9EE9-BBB4BAE31257 Q28541754-0535DD8F-8CAA-4AFC-BA5C-A5FE29BABA36 Q40250347-B66EF436-1065-405A-8AAA-E0A231E8F2E5 Q47252129-ABA554EA-FD20-43C1-836C-CF700E35028D Q52640420-53D89C55-D71A-4489-9954-1D8662D064E2 Q52666512-C2B6898E-C313-4B00-82B0-DB5EBEB2F021

P2860

Evolution of HIV treatment guidelines in high- and low-income countries: converging recommendations

http://www.wikidata.org/entity/Q34321843

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Evolution of HIV treatment gui ...... es: converging recommendations

@ast

Evolution of HIV treatment gui ...... es: converging recommendations

@en

Evolution of HIV treatment gui ...... es: converging recommendations

@nl

type

label

Evolution of HIV treatment gui ...... es: converging recommendations

@ast

Evolution of HIV treatment gui ...... es: converging recommendations

@en

Evolution of HIV treatment gui ...... es: converging recommendations

@nl

prefLabel

Evolution of HIV treatment gui ...... es: converging recommendations

@ast

Evolution of HIV treatment gui ...... es: converging recommendations

@en

Evolution of HIV treatment gui ...... es: converging recommendations

@nl

P1433

Q34321843-DCD97716-9408-4542-B2BB-C82C0742CEF0

P1476

Q34321843-97B060D6-9ECB-4E3C-9067-B61B2795D543

P2093

Q34321843-45ECEC1F-9459-47CF-9BC1-5B27DABA4228

Q34321843-5CB1B51B-15AD-467C-B355-3E8E901EA8EC

Q34321843-B1D8C2F3-2EBD-451D-B594-252E245C7B89

P2860

Q34321843-049B17F9-ABD4-4CB7-8D3F-1DC4F75396AA

Q34321843-06081A80-B7EB-4B6F-94A2-4B6F41617456

Q34321843-07A6F5CF-BEA6-4445-A3F6-4C4E77CD8472

Q34321843-0A7A4896-034B-482D-8E71-9724035F2C7F

Q34321843-1058BCDA-344D-4A73-914B-3E5BC6E7C8EF

Q34321843-129A56C3-72E9-43F5-8DE3-D053D16B3A07

Q34321843-140F6C30-A5BA-48C2-A0E7-E396C86F1BCA

Q34321843-1E4F9B49-0D9E-4661-8633-37FC7D902102

Q34321843-2D739D07-AE4A-416B-A13F-1EF58891E81C

Q34321843-34834DC3-6F43-4557-A8A2-B47720BFC296

P304

Q34321843-CC8C8F2B-155F-449E-A69B-E24F844AA2A4

P31

Q34321843-03C1D489-36DB-41FC-97B5-77C1340E58E1

P356

Q34321843-45C87A36-E010-4048-871A-12576F16249D

P478

Q34321843-0E978C4F-8659-428E-BF00-5D54838962DA

P577

Q34321843-4F3D7855-19BC-4BC4-A4C8-2ED0EF023C45

P698

Q34321843-C4DE1A6D-6D82-4E99-8D81-D68791189FF6

P932

Q34321843-1D284795-98C8-4572-8D10-2C6B959BD906

P356

J.ANTIVIRAL.2013.12.007

P1433

Antiviral Research

P1476

Evolution of HIV treatment gui ...... es: converging recommendations

@en

P2093

Andrew R Zolopa

http://www.w3.org/2001/XMLSchema#string

Eugene T Richardson

http://www.w3.org/2001/XMLSchema#string

Philip M Grant

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of HIV-1 infection with early antiretroviral therapy

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

Raltegravir with optimized background therapy for resistant HIV-1 infection

CD4+ count-guided interruption of antiretroviral treatment

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

Effect of early versus deferred antiretroviral therapy for HIV on survival.

When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.

Short-course antiretroviral therapy in primary HIV infection.

Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study.

P304

88-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ANTIVIRAL.2013.12.007

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24374148

http://www.w3.org/2001/XMLSchema#string

P932

4193472

http://www.w3.org/2001/XMLSchema#string